Global Neo-Endorphin 麻豆原创 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Publication ID:

GIR102401535

Publication Date:

October 2, 2024

Pages:

Publisher:

GIR

Countries:

Global [1]

USD 3,480.00

Pharmaceutical Manufacturing [2]

Healthcare [3]

Pharma & Healthcare [4]

Description:

The global Neo-Endorphin market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Neo-endorphin is a new member of the endorphin family about which relatively little is known. According to existing knowledge, Neo-endorphin may be a biochemically synthesized hormone secreted by the pituitary gland, which binds to opioid receptors on the cell surface and regulates the opening and closing of potassium, calcium and other ion channels in the cell membrane. Changes the resting potential of cells, thus exerting effects similar to morphine, including analgesic, euphoria, narrowing pupils, regulating body temperature, etc.
Under stress conditions of the body, such as exercise, painful stimulation, major blows to the body, etc., the release of Neo-endorphins can protect the body. In addition, activities such as jogging and eating spicy food may also promote the release of Neo-endorphins. However, excessive levels of Neo-endorphins may also have adverse health effects, including autism, depression, insomnia, frigidity, etc.
In summary, Neo-endorphin is a new member of endorphins with potential therapeutic applications, and more research is needed to deeply understand its biochemical properties, physiological effects, and pharmacological properties to provide a theory for the development of new therapeutic methods. Base.
This report includes an overview of the development of the Neo-Endorphin industry chain, the market status of Scientific Research (伪-狈别辞-贰苍诲辞谤辫丑颈苍, 尾-狈别辞-贰苍诲辞谤辫丑颈苍), Medical (伪-狈别辞-贰苍诲辞谤辫丑颈苍, 尾-狈别辞-贰苍诲辞谤辫丑颈苍), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Neo-Endorphin.
Regionally, the report analyzes the Neo-Endorphin markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Neo-Endorphin market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Neo-Endorphin market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Neo-Endorphin industry.
The report involves analyzing the market at a macro level:
麻豆原创 Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., 伪-狈别辞-贰苍诲辞谤辫丑颈苍, 尾-狈别辞-贰苍诲辞谤辫丑颈苍).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Neo-Endorphin market.
Regional Analysis: The report involves examining the Neo-Endorphin market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
麻豆原创 Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Neo-Endorphin market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Neo-Endorphin:
Company Analysis: Report covers individual Neo-Endorphin manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Neo-Endorphin This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Scientific Research, Medical).
Technology Analysis: Report covers specific technologies relevant to Neo-Endorphin. It assesses the current state, advancements, and potential future developments in Neo-Endorphin areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Neo-Endorphin market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
麻豆原创 Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
麻豆原创 Segmentation
Neo-Endorphin market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
麻豆原创 segment by Type
伪-狈别辞-贰苍诲辞谤辫丑颈苍
尾-狈别辞-贰苍诲辞谤辫丑颈苍
麻豆原创 segment by Application
Scientific Research
Medical
Others
Major players covered
Peptide Institute
Abbexa
Elabscience
Biosynth Carbosynth
Generon.co.uk
Phoenix Pharmaceuticals
Creative Peptides
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Neo-Endorphin product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Neo-Endorphin, with price, sales, revenue and global market share of Neo-Endorphin from 2019 to 2024.
Chapter 3, the Neo-Endorphin competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Neo-Endorphin breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Neo-Endorphin market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Neo-Endorphin.
Chapter 14 and 15, to describe Neo-Endorphin sales channel, distributors, customers, research findings and conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Product Overview and Scope of Neo-Endorphin
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Neo-Endorphin Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 伪-狈别辞-贰苍诲辞谤辫丑颈苍
1.3.3 尾-狈别辞-贰苍诲辞谤辫丑颈苍
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Neo-Endorphin Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Scientific Research
1.4.3 Medical
1.4.4 Others
1.5 Global Neo-Endorphin 麻豆原创 Size & Forecast
1.5.1 Global Neo-Endorphin Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Neo-Endorphin Sales Quantity (2019-2030)
1.5.3 Global Neo-Endorphin Average Price (2019-2030)
2 Manufacturers Profiles
2.1 Peptide Institute
2.1.1 Peptide Institute Details
2.1.2 Peptide Institute Major Business
2.1.3 Peptide Institute Neo-Endorphin Product and Services
2.1.4 Peptide Institute Neo-Endorphin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.1.5 Peptide Institute Recent Developments/Updates
2.2 Abbexa
2.2.1 Abbexa Details
2.2.2 Abbexa Major Business
2.2.3 Abbexa Neo-Endorphin Product and Services
2.2.4 Abbexa Neo-Endorphin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.2.5 Abbexa Recent Developments/Updates
2.3 Elabscience
2.3.1 Elabscience Details
2.3.2 Elabscience Major Business
2.3.3 Elabscience Neo-Endorphin Product and Services
2.3.4 Elabscience Neo-Endorphin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.3.5 Elabscience Recent Developments/Updates
2.4 Biosynth Carbosynth
2.4.1 Biosynth Carbosynth Details
2.4.2 Biosynth Carbosynth Major Business
2.4.3 Biosynth Carbosynth Neo-Endorphin Product and Services
2.4.4 Biosynth Carbosynth Neo-Endorphin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.4.5 Biosynth Carbosynth Recent Developments/Updates
2.5 Generon.co.uk
2.5.1 Generon.co.uk Details
2.5.2 Generon.co.uk Major Business
2.5.3 Generon.co.uk Neo-Endorphin Product and Services
2.5.4 Generon.co.uk Neo-Endorphin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.5.5 Generon.co.uk Recent Developments/Updates
2.6 Phoenix Pharmaceuticals
2.6.1 Phoenix Pharmaceuticals Details
2.6.2 Phoenix Pharmaceuticals Major Business
2.6.3 Phoenix Pharmaceuticals Neo-Endorphin Product and Services
2.6.4 Phoenix Pharmaceuticals Neo-Endorphin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.6.5 Phoenix Pharmaceuticals Recent Developments/Updates
2.7 Creative Peptides
2.7.1 Creative Peptides Details
2.7.2 Creative Peptides Major Business
2.7.3 Creative Peptides Neo-Endorphin Product and Services
2.7.4 Creative Peptides Neo-Endorphin Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2019-2024)
2.7.5 Creative Peptides Recent Developments/Updates
3 Competitive Environment: Neo-Endorphin by Manufacturer
3.1 Global Neo-Endorphin Sales Quantity by Manufacturer (2019-2024)
3.2 Global Neo-Endorphin Revenue by Manufacturer (2019-2024)
3.3 Global Neo-Endorphin Average Price by Manufacturer (2019-2024)
3.4 麻豆原创 Share Analysis (2023)
3.4.1 Producer Shipments of Neo-Endorphin by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2023
3.4.2 Top 3 Neo-Endorphin Manufacturer 麻豆原创 Share in 2023
3.4.2 Top 6 Neo-Endorphin Manufacturer 麻豆原创 Share in 2023
3.5 Neo-Endorphin 麻豆原创: Overall Company Footprint Analysis
3.5.1 Neo-Endorphin 麻豆原创: Region Footprint
3.5.2 Neo-Endorphin 麻豆原创: Company Product Type Footprint
3.5.3 Neo-Endorphin 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Neo-Endorphin 麻豆原创 Size by Region
4.1.1 Global Neo-Endorphin Sales Quantity by Region (2019-2030)
4.1.2 Global Neo-Endorphin Consumption Value by Region (2019-2030)
4.1.3 Global Neo-Endorphin Average Price by Region (2019-2030)
4.2 North America Neo-Endorphin Consumption Value (2019-2030)
4.3 Europe Neo-Endorphin Consumption Value (2019-2030)
4.4 Asia-Pacific Neo-Endorphin Consumption Value (2019-2030)
4.5 South America Neo-Endorphin Consumption Value (2019-2030)
4.6 Middle East and Africa Neo-Endorphin Consumption Value (2019-2030)
5 麻豆原创 Segment by Type
5.1 Global Neo-Endorphin Sales Quantity by Type (2019-2030)
5.2 Global Neo-Endorphin Consumption Value by Type (2019-2030)
5.3 Global Neo-Endorphin Average Price by Type (2019-2030)
6 麻豆原创 Segment by Application
6.1 Global Neo-Endorphin Sales Quantity by Application (2019-2030)
6.2 Global Neo-Endorphin Consumption Value by Application (2019-2030)
6.3 Global Neo-Endorphin Average Price by Application (2019-2030)
7 North America
7.1 North America Neo-Endorphin Sales Quantity by Type (2019-2030)
7.2 North America Neo-Endorphin Sales Quantity by Application (2019-2030)
7.3 North America Neo-Endorphin 麻豆原创 Size by Country
7.3.1 North America Neo-Endorphin Sales Quantity by Country (2019-2030)
7.3.2 North America Neo-Endorphin Consumption Value by Country (2019-2030)
7.3.3 United States 麻豆原创 Size and Forecast (2019-2030)
7.3.4 Canada 麻豆原创 Size and Forecast (2019-2030)
7.3.5 Mexico 麻豆原创 Size and Forecast (2019-2030)
8 Europe
8.1 Europe Neo-Endorphin Sales Quantity by Type (2019-2030)
8.2 Europe Neo-Endorphin Sales Quantity by Application (2019-2030)
8.3 Europe Neo-Endorphin 麻豆原创 Size by Country
8.3.1 Europe Neo-Endorphin Sales Quantity by Country (2019-2030)
8.3.2 Europe Neo-Endorphin Consumption Value by Country (2019-2030)
8.3.3 Germany 麻豆原创 Size and Forecast (2019-2030)
8.3.4 France 麻豆原创 Size and Forecast (2019-2030)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2019-2030)
8.3.6 Russia 麻豆原创 Size and Forecast (2019-2030)
8.3.7 Italy 麻豆原创 Size and Forecast (2019-2030)
9 Asia-Pacific
9.1 Asia-Pacific Neo-Endorphin Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Neo-Endorphin Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Neo-Endorphin 麻豆原创 Size by Region
9.3.1 Asia-Pacific Neo-Endorphin Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Neo-Endorphin Consumption Value by Region (2019-2030)
9.3.3 China 麻豆原创 Size and Forecast (2019-2030)
9.3.4 Japan 麻豆原创 Size and Forecast (2019-2030)
9.3.5 Korea 麻豆原创 Size and Forecast (2019-2030)
9.3.6 India 麻豆原创 Size and Forecast (2019-2030)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2019-2030)
9.3.8 Australia 麻豆原创 Size and Forecast (2019-2030)
10 South America
10.1 South America Neo-Endorphin Sales Quantity by Type (2019-2030)
10.2 South America Neo-Endorphin Sales Quantity by Application (2019-2030)
10.3 South America Neo-Endorphin 麻豆原创 Size by Country
10.3.1 South America Neo-Endorphin Sales Quantity by Country (2019-2030)
10.3.2 South America Neo-Endorphin Consumption Value by Country (2019-2030)
10.3.3 Brazil 麻豆原创 Size and Forecast (2019-2030)
10.3.4 Argentina 麻豆原创 Size and Forecast (2019-2030)
11 Middle East & Africa
11.1 Middle East & Africa Neo-Endorphin Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Neo-Endorphin Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Neo-Endorphin 麻豆原创 Size by Country
11.3.1 Middle East & Africa Neo-Endorphin Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Neo-Endorphin Consumption Value by Country (2019-2030)
11.3.3 Turkey 麻豆原创 Size and Forecast (2019-2030)
11.3.4 Egypt 麻豆原创 Size and Forecast (2019-2030)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2019-2030)
11.3.6 South Africa 麻豆原创 Size and Forecast (2019-2030)
12 麻豆原创 Dynamics
12.1 Neo-Endorphin 麻豆原创 Drivers
12.2 Neo-Endorphin 麻豆原创 Restraints
12.3 Neo-Endorphin Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Neo-Endorphin and Key Manufacturers
13.2 Manufacturing Costs Percentage of Neo-Endorphin
13.3 Neo-Endorphin Production Process
13.4 Neo-Endorphin Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Neo-Endorphin Typical Distributors
14.3 Neo-Endorphin Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

Companies Mentioned:

Peptide Institute
Abbexa
Elabscience
Biosynth Carbosynth
Generon.co.uk
Phoenix Pharmaceuticals
Creative Peptides

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.